Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2022  |  Volume : 18  |  Issue : 79  |  Page : 540-547

Esculetin ameliorates cognitive impairments in D-galactose-induced Alzheimer's disease rats by inhibiting inflammation and oxidative stress


Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China

Correspondence Address:
Huibo Guan
Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang - 150040
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_524_21

Rights and Permissions

Background: Alzheimer disease (AD) is a common form of dementia and is described by memory loss and behavioral disorder. The prevalence of AD is increasing rapidly each year worldwide. Objectives: In this study, we aimed to discover the therapeutic properties of esculetin against D-galactose (D-gal)-induced AD in an animal model. Materials and Methods: AD was initiated in rats by administering 150 mg/kg of D-gal via subcutaneous route for 6 weeks and supplemented with 10, 20, and 30 mg/kg of esculetin, respectively. Subsequently, memory and learning of the rats were investigated using the Morris water maze (MWM). The organ index of the liver, spleen, thymus, and kidneys was assessed. The enzyme activities of superoxide dismutase (SOD), catalase (CAT), GSH-Px, and heme oxygenase-1 (HO-1) and the levels of advanced glycation end products (AGEs), 8-iso-prostaglandin F (8-iso-PGF), and 8-hydroxy-2-deoxyguanosine (8-OHdG) were assessed using commercially available kits. The level of acetylcholine (Ach) and the activity of acetylcholinesterase (AChE) was also assessed using kits. The brain tissue samples were assessed microscopically. Results: According to the results, esculetin significantly improved the bodyweight and organ index in AD animals. It significantly modulated the spatial learning and memory and improved the activities of CAT, SOD, GSH-Px, and HO-1. It significantly reduced the contents of AGEs, 8-iso-PGF, and 8-OHdG and inflammatory markers. Furthermore, esculetin increased the level of ACh and the reduced activity of AChE. Histological analysis of the brain tissue revealed that esculetin attenuated the D-gal-induced histological changes in the brain of AD rats. Conclusion: The findings of this study reveal that esculetin can ameliorate inflammation and oxidative damage in D-gal-induced AD rats. It can be further explored as a therapeutic agent to treat AD.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed120    
    Printed4    
    Emailed0    
    PDF Downloaded32    
    Comments [Add]    

Recommend this journal